Related Experiment Videos
Decrease of thrombomodulin contributes to the procoagulant state of endothelium in hemolytic uremic syndrome
Gabriela C Fernández1, Maroeska W M Te Loo, Thea J A van der Velden
1División Inmunología, IIHEMA, Academia Nacional de Medicina, Buenos Aires, Argentina. gfernandez@hematologia.anm.edu.ar
Pediatric Nephrology (Berlin, Germany)
|August 16, 2003
Summary
Shiga-like toxin 2 (Stx2) significantly reduces thrombomodulin (TM) on human glomerular endothelial cells, potentially contributing to hemolytic uremic syndrome (HUS). This toxin-induced decrease in TM may promote a procoagulant state in HUS.
Area of Science:
- Nephrology
- Microbiology
- Cell Biology
Background:
- Hemolytic uremic syndrome (HUS) is a thrombotic microangiopathy causing acute kidney injury in children.
- Shiga-like toxin (Stx)-producing bacteria are the primary cause of typical HUS (D+HUS).
- Endothelial cell (EC) injury is central to D+HUS pathogenesis, with thrombomodulin (TM) playing a key role in regulating coagulation.
Purpose of the Study:
- To investigate the impact of Stx on thrombomodulin (TM) surface expression in human glomerular microvascular endothelial cells (hGECs).
- To evaluate the role of inflammatory mediators like tumor necrosis factor-alpha (TNF-alpha) in modulating Stx effects on TM expression.
- To understand the contribution of Stx-induced TM downregulation to the procoagulant state in D+HUS.
Main Methods:
- In vitro culture of human glomerular microvascular endothelial cells.
- Treatment with Shiga-like toxin 2 (Stx2) and tumor necrosis factor-alpha (TNF-alpha).
- Assessment of thrombomodulin (TM) surface expression using flow cytometry and Western blotting.
- Evaluation of protein synthesis inhibition using cycloheximide.
Main Results:
- Stx2 significantly decreased TM surface expression on hGECs, particularly after pre-incubation with TNF-alpha.
- The reduction in TM expression was not solely due to the inhibition of protein synthesis.
- Cycloheximide, an inhibitor of protein synthesis, did not affect TM surface expression.
Conclusions:
- Stx2 downregulates TM expression in glomerular endothelial cells.
- This downregulation is likely a direct effect of Stx2, not just a general inhibition of protein synthesis.
- The Stx2-induced decrease in TM may contribute to the procoagulant environment characteristic of D+HUS.